Fairmount Healthcare Fund II L.P., Director, 10% Owner at Viridian Therapeutics, Inc.\DE (VRDN), bought 1,600,000 shares at $18.75 ($30.0M) on 2024-09-13, disclosed to the SEC on 2024-09-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.